Affiliation:
1. Omsk State Medical University
Abstract
Currently, proton pump inhibitors (PPIs), H2-histamine receptor blockers (H2-blockers), antacids, and anticholinergics are used to treat acid-dependent diseases of the gastrointestinal tract. PPIs are considered the most effective drugs for the treatment of acid-dependent diseases of the gastrointestinal tract. However, in real clinical practice, interest remains in the use of antacids in acid-dependent diseases. This is due to the fact that antacids not only adsorb hydrochloric acid in the gastric lumen (by buffering the HCl present in the stomach, without a significant effect on its production) and reduce the proteolytic activity of gastric juice (reducing/ neutralizing the activity of pepsin), but also have a number of other pharmacotherapeutic properties demanded by the gastroenterological patient. Antacids in addition to antisecretory action have: 1) cytoprotective, primarily gastroprotective, action, which is mediated by: a) stimulation of the synthesis of bicarbonates and prostaglandins; b) mucoprotection – an increase in the production of protective mucus by epithelial cells; c) switching of the epithelial growth factor and its concentration in the area of erosive and ulcerative defects, which in turn activates angiogenesis, cell proliferation and local reparative and regenerative processes; 2) enveloping and adsorbing action, through chelation of lysolecithin and bile acids, which have an aggressive damaging effect on the upper gastrointestinal tract; 3) regulate gastroduodenal motility due to: a) antispasmodic action and streamlining gastroduodenal evacuation; b) decrease in intracavitary pressure in the stomach and duodenum; b) obstacles to the formation of duodenogastric reflux. To date, combined preparations, the basic composition of which includes magnesium hydroxide and aluminum hydroxide, meet the basic requirements for non-absorbable antacids. In conclusion, the authors present a number of clinical situations, indicating that today rationally prescribed antacid drugs successfully and significantly solve the main tasks of symptomatic therapy of acid-dependent and other diseases of the gastrointestinal tract, significantly improving the quality of life of patients.
Reference58 articles.
1. Trukhan D.I., Viktorova I.A. Internal diseases: Gastroenterology. St Petersburg: SpecLit; 2013. 367 р. (In Russ.) Available at: https://www.gastroscan.ru/literature/pdf/trukhan-viktorova-2013.pdf.
2. Ivanova O.I., Minushkin O.N. Antacids in the modern treatment of acidbase disorders. Meditsinskiy Sovet. 2015;(13):30–37. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/332.
3. Andreev D.N., Baranskaya Е.K., Burkov S.G., Derinov A.A., Efetov S.K., Ivashkin V.T. et al. Peptic ulcer disease: clinical recommendations. Moscow; 2020. (In Russ.) Available at: https://cr.minzdrav.gov.ru/schema/277_1#doc_a1.
4. Ivashkin V.T., Maev I.V., Trukhmanov A.S., Lapina T.L., Storonova O.A., Zayratyants O.V. et al. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(4):70–97. (In Russ.) https://doi.org/10.22416/1382-4376-2020-30-4-70-97.
5. Targownik L.E., Lix L.M., Leung S., Leslie W.D. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology. 2010;138(3):896–904. https://doi.org/10.1053/j.gastro.2009.11.014.